Name
Genasense
Alternate Names
Augmerosen
Bcl-2 antisense Oligonucleotide
G 3139
G-3139
GC 3139
GC-3139
Oblimersen
Oblimersen sodium
Abbreviations
None
Category
Chemotherapy
Subcategory
Apoptosis inducer
NSC Number
683428
Primary Site
Breast
colorectal
kidney
leukemia
lung
lymphoma
melanoma
multiple myeloma
pancreatic cancer
prostate
sarcoma
Histology
None
Remarks
Phase II (breast), Phase III AML, CLL, NSCLC, MM, prostate, melanoma, Phase I (colorectal), Phase I/II NHL, sarcoma Antisense. Phosphorothioate antisense oligonucleotide which targets human Bcl-2 mRNA. Genta Inc., Aventis.
Coding
This drug should be coded